There are 2789 resources available
21P - Analysis of germline variants in the immune response-related genes in BRCA1 mutation carriers: Possible modifying effect on age-dependent BRCA1 penetrance
Presenter: Ekaterina Kuligina
Session: ePoster Display
22P - Functional characterization of DIRC3 long non-coding RNA in differentiated thyroid cancer
Presenter: Piotr Tomasz Wysocki
Session: ePoster Display
23P - Transcriptional profiling of circulating tumor and hybrid cells in breast cancer patients
Presenter: Evgeny Denisov
Session: ePoster Display
Resources:
Abstract
24P - The STAT3 phosphorylation status discriminates tumor associated populations in myeloid cell tumor-infiltrating model
Presenter: Ester Palmeiro
Session: ePoster Display
25P - Targeting arginine deprivation in dinaciclib-resistant glioblastoma multiforme cells
Presenter: Katharina del Moral
Session: ePoster Display
48P - (BREGO) Regorafenib combined with modified m-GEMOX in patients with advanced biliary tract cancer (BTC): A phase II randomized trial
Presenter: Eric Assenat
Session: ePoster Display
49P - A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer
Presenter: Nai-Jung Chiang
Session: ePoster Display
51P - Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
52P - Assessment of futibatinib exposure–response (E–R) relationships in patients with advanced solid tumors, including cholangiocarcinoma (CCA)
Presenter: Antoine Hollebecque
Session: ePoster Display